nach oben

CNS Drugs

Erschienen in:

01.06.2000 | Disease Management

Epidemiology, Pathophysiology and Treatment of Pathological Gambling

verfasst von: Dr Carlos Blanco, Angela Ibáñez, Jerónimo Sáiz-Ruiz, Carmen Blanco-Jerez, Edward V. Nunes

Erschienen in: CNS Drugs | Ausgabe 6/2000

Einloggen, um Zugang zu erhalten

Abstract

Pathological gambling is a prevalent disorder that is gaining attention from patients, clinicians and policy makers. Aetiological factors that have been related to pathological gambling include: (i) abnormalities in the serotonergic, dopaminergic and noradrenergic systems; (ii) cognitive distortions; and (iii) a reinforcement of the gambling activity by either episodic gains or the excitement that accompanies gambling. Male gender, urban residence, lower income and the presence of a comorbid psychiatric disorder (particularly substance abuse) appear to constitute risk factors for the presence of the disorder.

A number of treatments have been suggested as potentially effective: Gamblers Anonymous, behavioural therapy, manualised cognitive therapy and several medications. At present, only manualised cognitive therapy and the selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor fluvoxamine have shown efficacy in systematic (albeit small) studies. However, much research remains to be done to better understand the psychophysiology of pathological gambling, to firmly demonstrate the efficacy of the different proposed treatment approaches, and to establish criteria for treatment selection for individual patients.

American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders. 3rd ed. Washington, DC: AmericanPsychiatric Press, 1980

Ciarrocchi J, Richardson R. Profile of compulsive gamblers intreatment: update and comparisons. J Gambling Behav 1989;5: 53–65CrossRef

Petry NM, Armentano C. Prevalence, assessment, and treatment of pathological gambling: a review. Psychiatr Serv 1999; 50:1021–7PubMed

Shaffer HJ, Hall MN, Vanderbilt J. Estimating the prevalenceof disordered gambling behavior in the United States and Canada: a meta-analysis [report]. Boston (MA): Harvard University,1997

Lesieur HR, Rosenthal RJ. Pathological gambling: a review of the literature. J Gambling Stud 1991; 7: 5–40CrossRef

Shaffer HJ, Hall MN, Vanderbilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: aresearch synthesis. Am J Public Health 1999; 89: 1369–76PubMedCrossRef

Volberg RA. The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 1994; 84(2): 237–41PubMedCrossRef

Lesieur HR, Blume SB, Zoppa RM. Alcoholism, drug abuse and gambling. Alcohol Clin Exp Res 1986; 10(1): 33–8PubMedCrossRef

Browne BA, Brown DJ. Predictors of lottery gambling among American college students. J Soc Psychol 1994; 134(3): 339–47PubMedCrossRef

10.

Zeitlin H. Children with alcohol misusing parents. Br Med Bull 1994; 50(1): 139–51PubMed

11.

Lesieur HR, Cross J, Frank M, et al. Gambling and pathological gambling among university students. Addict Behav 1991; 16: 517–27PubMedCrossRef

12.

Volberg RA, Abbott MW. Lifetime prevalence estimates of pathological gambling in New Zealand. Int J Epidemiol 1994; 23: 976–83PubMedCrossRef

13.

Freud S. Dostoevsky and parricide 1928. In: Strachey J, editor and translator. The complete psychological works of Sigmund Freud. Standard edition. Vol. XIX. London: The Hogart Press, 1981: 157–170

14.

Bergler E. The psychology of gambling. New York (NY): International University Press, 1958

15.

Rosenthal RJ. The psychodynamics of pathological gambling: a review of the literature. In: Galski T, editor. The handbook of pathological gambling. Springfield (IL): Charles C. Thomas Publisher, Ltd, 1987

16.

Morán E. Clinical and social aspects of risk-taking. Proc R Soc Med 1970; 63: 1273–5PubMed

17.

Brown R. Arousal and sensation-seeking components in the general explanation of gambling and gambling addictions. Int J Addict 1986; 21: 1001–16PubMed

18.

McConaghy N, Armstrong MS, Blaszcynski AP, et al. Behavior completion versus stimulus control in compulsive gambling. Implications for behavioral assessment. Behav Modif 1988; 12(3): 371–84PubMedCrossRef

19.

Ladouceur R, Mayrand M, Tourigny Y Risk taking behavior in gamblers and nongamblers during prolonged exposure. J Gambling Behav 1987; 3: 115–22CrossRef

20.

Moreno I, Saiz-Ruiz J, Lopez-Ibor Aliño JJ. Serotonin and gambling dependence. Human Psychopharmacol 1991; 6: S9–12CrossRef

21.

DeCaria CM, Hollander E, Grossman R, et al. Diagnosis, neurobiology and treatment of pathological gambling. J Clin Psychiatry 1996; 57 Suppl. 8: 80–4PubMed

22.

Pérez de Castro I, Ibáñez A, Sáiz-Ruiz J, et al. Genetic contribution to pathological gambling: association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected males. Pharmacogenetics 1999; 9: 397–400PubMed

23.

Blanco C, Oresanz-Muñoz L, Bianco-Jerez C, et al. Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry 1996; 153: 119–21PubMed

24.

Ibáñez A, Pérez de Castro I, Fernández-Piqueras J, et al. Genetic association study between pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 2000; 5: 105–9PubMedCrossRef

25.

Roy A, Adinoff B, Roehrich L et al. Pathological gambling: a psychobiological study. Arch Gen Psychiatry 1988; 45: 369–73PubMedCrossRef

26.

Roy A, Dejong J, Linnoila M. Extraversion in pathological gamblers. Arch Gen Psychiatry 1989; 46: 679–81PubMedCrossRef

27.

DeCaria C, Hollander E, Nora R, et al. Gambling: biological/ genetic, treatment, government, and gambling concerns: neurobiology of pathological gambling. Presented at the 150th Annual Meeting of the American Psychiatric Association (APA): 1997 May 17–22; San Diego (CA)

28.

Bergh C, Eklund T, Sodersten P, et al. Altered dopamine functionin pathological gambling. Psychol Med 1997; 27(2): 473–5PubMedCrossRef

29.

Perez de Castro I, Ibáñez A, Torres P, et al. Genetic associationstudy between pathological gambling and a functional DNA polymorphism at the D4 receptor. Pharmacogenetics 1997; 7: 345–8PubMed

30.

Lesieur HR, Blume SB. The South Oaks Gambling Screen(SOGS): a new instrument for the identification of pathological gamblers. Am J Psychiatry 1987; 144(9): 1184–8PubMed

31.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev. ed. Washington, DC: American Psychiatric Press, 1987

32.

Johnson EE, Hamer R, Nora RM, et al. The Lie/Bet Questionnaire for screening pathological gamblers. Psychol Rep 1997; 80: 83–8PubMedCrossRef

33.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994

34.

World Health Organization. International classification of diseases. 10th ed. Geneva: World Health Organization, 1992

35.

Lesieur HR, Blume SB. Evaluation of patients treated for pathological gambling in a combined alcohol, substance abuse and pathological gambling treatment unit using the Addiction SeverityIndex. Br J Addict 1991; 86: 1017–28PubMedCrossRef

36.

DeCaria CM, Hollander E, Begaz T, et al. Reliability and validity of a pathological gambling modification of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS): preliminary findings. Presented at the 12th National Conference on Pathological Gambling: 1998 Jul 13–15; Las Vegas (NV)

37.

Lesieur HR, Heineman M. Pathological gambling among youthfulmultiple substance abusers in a therapeutic community. Br J Addict 1988; 83: 765–71PubMedCrossRef

38.

McCormick RA, Russo AM, Ramirez LF, et al. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984; 142: 215–8

39.

Specker SM, Carlson GA, Christenson GA, et al. Impulse control disorders and attention deficit disorder in pathological gamblers. Ann Clin Psychiatry 1995; 7: 175–9PubMedCrossRef

40.

Bland RC, Newman SC, Orn H, et al. Epidemiology of pathological gambling in Edmonton. Can J Psychiatry 1993; 38: 108–12PubMed

41.

Cunningham-Williams RM, Cottler LB, Compton WM, et al. Taking chances: problem gamblers and mental health disorders: results from the St. Louis Epidemiological Catchement Area Study. Am J Public Health 1998; 88: 1093–6PubMedCrossRef

42.

Daghestani AN, Elenz E, Crayton JW. Pathological gambling in hospitalized substance abusing veterans. J Clin Psychiatry 1996; 57(8): 360–3PubMed

43.

Taber JI, McCormick RA, Russo AM, et al. Follow-up of pathological gamblers after treatment. Am J Psychiatry 1987; 148: 757–61

44.

Thorson JA, Powell FC, Hilt M. Epidemiology of gambling and depression in an adult sample. Psychol Rep 1994; 74(3): 987–94PubMedCrossRef

45.

Blaszczynski A, McConaghy N, Frankova A. Crime, antisocialpersonality and pathological gambling. Gambling Behav 1989; 5: 137–52CrossRef

46.

Stewart RM, Brown RIF. An outcome study of gamblers anonymous. Br J Psychiatry 1988; 152: 284–8PubMedCrossRef

47.

Johnson EE, Nora RM. Does spousal participation in GamblersAnonymous benefit compulsive gamblers? Psychol Rep 1992; 71(3 Pt 1): 914PubMed

48.

Tepperman JH. The effectiveness of short-term group therapy upon the pathological gambler and wife. J Gambling Behav 1985; 1: 119–30CrossRef

49.

Blackman S, Simone RV, Thoms DR. The Gamblers Treatment Clinic of St. Vincent’s North Richmond Community Mental Health Center: characteristics of the clients and outcome of treatment. Int J Addict 1989; 24: 29–37

50.

Russo A, Taber J, McCormick R, et al. An outcome study of an inpatient treatment program for pathological gamblers. Hosp Community Psychiatry 1984; 35: 823–7PubMed

51.

Bergler E. The psychology of gambling. New York (NY): Hilland Wang, 1957

52.

Bujold A, Ladouceur R, Sylvain C, et al. Treatment of pathological gamblers: an experimental study. J Behav Ther Exp Psychiatry 1994; 25: 275–82PubMedCrossRef

53.

Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: a controlled study. J Consult Clin Psychol 1997; 65: 727–32PubMedCrossRef

54.

Hollander E, Frenkel M, DeCaria C, et al. Treatment of pathological gambling with clomipramine [letter]. Am J Psychiatry 1992; 149: 710–1PubMed

55.

Hollander E, DeCaria C, Mari E, et al. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155: 1781–3PubMed

56.

Moskowitz JA. Lithium and lady luck. N Y State J Med 1980; 785–8

57.

Moreno I, Sáiz Ruiz J. Tratamiento de un caso de ludopatía(juego patológico) con sales de litio. In: Cacabelos R, editor.Anuario Psiquiátrico. Barcelona: Prous, 1991: 249–54

58.

Haller R, Hinterhuber H. Treatment of pathological gamblingwith carbamazepine. Pharmacopsychiatry 1994; 27(3): 129PubMedCrossRef

59.

Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998; 59: 159–64PubMedCrossRef

60.

Turón JV, Salgado P, González A, et al. Tratamiento farmacológico del juego patológico. Actas de la XV Reunión de la Sociedad Española de Psiquiatría Biológica: 1990 Nov 4–6; Córdoba, 368-75

61.

Hollander E, DeCaria C, Finkell JN, et al. A randomized double-blind fluvoxamine/placebo cross-over trial in pathological gambling. Biol Psychiatry. In press

Titel: Epidemiology, Pathophysiology and Treatment of Pathological Gambling
verfasst von: Dr Carlos Blanco
Angela Ibáñez
Jerónimo Sáiz-Ruiz
Carmen Blanco-Jerez
Edward V. Nunes
Publikationsdatum: 01.06.2000
Verlag: Springer International Publishing
Erschienen in: CNS Drugs / Ausgabe 6/2000
Print ISSN: 1172-7047
Elektronische ISSN: 1179-1934
DOI: https://doi.org/10.2165/00023210-200013060-00002

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2000

Metrifonate

Role of Newer Atypical Antipsychotics in the Management of Treatment-Resistant Schizophrenia

Atypical Antipsychotics in the Treatment of Bipolar Disorder

Evidence for Psychotropic Effects of Acetylcholinesterase Inhibitors